{"id":"W2073375464","doi":"10.1158/1538-7445.am2013-2199","title":"Abstract 2199: Associations of genetic polymorphisms in <i>VEGFR1</i> with progression-free and overall survival in patients with neuroendocrine tumors treated with the VEGFA inhibitor bevacizumab.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Bevacizumab; Single-nucleotide polymorphism; Internal medicine; Oncology; Hazard ratio; Proportional hazards model; Medicine; Progression-free survival; Genotyping; Minor allele frequency; Vascular endothelial growth factor A; Genotype; Vascular endothelial growth factor; Biology; Chemotherapy; VEGF receptors; Confidence interval; Gene; Genetics","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004845823,0.0002828802,0.0003708273,0.0003451599,0.0002537995,0.0003891816,0.0002926965,0.0003809153,0.001690676],"category_scores_gemma":[0.001108044,0.0001497713,0.0006583385,0.0006002282,0.0001711244,0.0001525295,0.0002176063,0.0004498848,0.0002453976],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002124467,"about_ca_system_score_gemma":0.0001980554,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001657261,"about_ca_topic_score_gemma":0.001985588,"domain_scores_codex":[0.9996246,0.00008789985,0.00004299569,0.0001532668,0.00005180684,0.00003934399],"domain_scores_gemma":[0.999161,0.000276455,0.0003579057,0.00006896158,0.0000416596,0.00009400132],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.004137345,0.0001064024,0.9751202,0.00005231062,0.001123013,0.0003094628,0.00005733047,0.0005920068,0.01228388,0.00006702611,0.0006272352,0.005523754],"study_design_scores_gemma":[0.0001637514,0.0003698406,0.9948351,0.000008889016,0.0006386096,0.0005830285,0.00003279328,0.001209083,0.001347217,0.000116479,0.0006842929,0.00001079582],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9983543,0.0001969555,0.0001807794,0.00004979339,0.000009871176,0.00000608961,0.0009995555,0.000007865471,0.0001946824],"genre_scores_gemma":[0.9985033,0.00003191274,0.000171404,0.00002812797,0.00001586172,0.000008755965,0.001066491,0.000005810067,0.0001682943],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001690676,"threshold_uncertainty_score":0.005655885,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02501923548673464,"score_gpt":0.3319644849082787,"score_spread":0.3069452494215441,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}